TissueTech raises $10M for regenerative medicine businesses

08/23/2013 | MassDevice.com (Boston)

TissueTech has secured $10 million in financing from River Cities Capital Funds and Ballast Point Ventures. The Doral, Fla.-based company will use the money to support research and development as well as fund the commercialization of regenerative medicine products developed by its Amniox Medical and Bio-Tissue units.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC